by McKesson Ventures | May 10, 2021 | Media Coverage
US Oncology Research, supported by McKesson and the US Oncology Network, has a network of experienced and dedicated clinical staff and investigators who specialize in Phase I through Phase IV clinical trials. Robert Coleman, MD, FACOG, FACS, serves as its Chief...
by McKesson Ventures | Apr 30, 2021 | Media Coverage
Alula, McKesson’s first digital cancer treatment marketplace partner, opened up its DTC marketplace in April. The purpose? Make it easier for cancer patients to find and purchase the products they need at any given stage of their treatment. Liya Shuster-Bier was a...
by McKesson Ventures | Apr 27, 2021 | Media Coverage
Michelle Snyder is McKesson Ventures’ newest partner, having joined the firm in late 2020. But Snyder is a digital health veteran and she’s seen innovation in the industry from every angle, from marketing to mentoring to investing. In a recent StartUp Health Fireside...
by McKesson Ventures | Apr 23, 2021 | Media Coverage
McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...
by McKesson Ventures | Apr 20, 2021 | Media Coverage
In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in...
by McKesson Ventures | Apr 6, 2020 | Media Coverage
McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order...
